XML 48 R35.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Stock-based Compensation Expense
Stock-based compensation expense by income statement caption and the related income tax benefit were as follows:
 
Three Months Ended March 31,
(In thousands)
2017
 
2016
Cost of sales
$
15

 
$
14

Research and development expenses
119

 
136

Selling, general and administrative expenses:
 
 
 
Employees
1,744

 
1,845

Outside directors
745

 
498

Total employee and director stock-based compensation expense
$
2,623


$
2,493

 
 
 
 
Income tax benefit
$
815

 
$
733

Schedule of Stock Option Activity
Stock option activity was as follows:
 
Number of Options
(in 000's)
 
Weighted-Average Exercise Price
 
Weighted-Average Remaining Contractual Term
(in years)
 
Aggregate Intrinsic Value
(in 000's)
Outstanding at December 31, 2016
652

 
$
39.27

 
 
 
 
Granted
92

 
62.70

 
 
 
 
Exercised
(8
)
 
29.53

 
 
 
$
306

Forfeited/canceled/expired

 

 
 
 
 
Outstanding at March 31, 2017 (1)
736

 
$
42.30

 
4.86
 
$
19,275

Vested and expected to vest at March 31, 2017 (1)
736

 
$
42.30

 
4.86
 
$
19,272

Exercisable at March 31, 2017 (1)
452

 
$
34.30

 
4.10
 
$
15,450

(1) 
The aggregate intrinsic value represents the total pre-tax value (the difference between our closing stock price on the last trading day of the first quarter of 2017 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had they all exercised their options on March 31, 2017. This amount will change based on the fair market value of our stock.
Schedule of Black Scholes Assumptions
The assumptions we utilized in the Black-Scholes option pricing model and the resulting weighted average fair value of stock option grants were the following:
 
Three Months Ended March 31,
 
2017
 
2016
Weighted average fair value of grants
$19.61
 
$17.96
Risk-free interest rate
1.75%
 
1.36%
Expected volatility
34.25%
 
41.38%
Expected life in years
4.52
 
4.55

Schedule of Non-vested Restricted Stock Awards Activity
Non-vested restricted stock award activity was as follows:
 
Shares
(in 000's)
 
Weighted-Average Grant Date Fair Value
Non-vested at December 31, 2016
153

 
$
57.43

Granted
98

 
63.39

Vested
(26
)
 
56.94

Forfeited
(1
)
 
58.95

Non-vested at March 31, 2017
224

 
$
60.09